News

February 14, 2019

Squarex Announces Publication of Clinical Results for SQX770 for the Prevention of Herpes Outbreaks in Immunity, Inflammation and Disease

December 20, 2018

Squarex to Present at Biotech Showcase 2019

Additional News

A phase 2 clinical trial of our drug, squaric acid dibutyl ester, has opened at Massachusetts General Hospital and Stanford University. This is a placebo-controlled double-blind clinical trial in persons with frequent cold sores aimed at providing further evidence of efficacy of the drug in preventing cold sores.